Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Shares")
-
Shares outstanding
-
194,615,320
-
Total 13F shares
-
46,886,789
-
Share change
-
+356,223
-
Total reported value
-
$1,478,128,925
-
Price per share
-
$31.57
-
Number of holders
-
73
-
Value change
-
+$22,763,370
-
Number of buys
-
42
-
Number of sells
-
32
Institutional Holders of Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (the "Shares") (RVMD) as of Q2 2020
As of 30 Jun 2020,
Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (the "Shares") (RVMD) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,886,789 shares.
The largest 10 holders included
TRV GP III, LLC, Svennilson Peter, FMR LLC, BOXER CAPITAL, LLC, Cormorant Asset Management, LP, TRV GP II, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), TRV GP IV, LLC, Casdin Capital, LLC, and VANGUARD GROUP INC.
This page lists
73
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.